![Julie Burek](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Julie Burek worked as a Senior Manager-Finance at Biogen, Inc. from 2013 to 2018.
She then joined Voyager Therapeutics, Inc. as a Vice President-Finance in 2018 and will continue in that role until 2023.
Ms. Burek completed her undergraduate degree at Bentley University and holds an MBA from Northeastern University.
Eerdere bekende functies van Julie Burek
| Bedrijven | Functie | Einde |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Financieel Directeur/CFO | 19-09-2022 |
| BIOGEN INC. | Corporate Officer/Principal | 01-04-2018 |
Opleiding van Julie Burek
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
76
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
